Cryo-Cell International is engaged in cellular processing and cryogenic storage, with a focus on the collection and preservation of umbilical cord blood and tissue stem cells for family use and the manufacture of PrepaCyte® CB Processing System units, the processing technology used to process umbilical cord blood stem cells and cellular processing and cryogenic storage of umbilical cord blood stem cells for public use. Co. stores cord blood and cord tissue specimens for the benefit of newborn babies and possibly other members of their families. Co. also provides cord tissue service, which stores a section of the umbilical cord tissue. We show 6 historical shares outstanding datapoints in our CCEL shares outstanding history coverage, used to compute CCEL market cap on those dates.
Understanding the changing numbers of shares outstanding, the changing
share price, and the resulting changing CCEL market cap history over the course of time is important for investors
interested in comparing CCEL's market cap history versus its peers.
Many "beginner" or "novice" investors will look at one stock trading at a price of $10 per share and another trading at
a price of $20 per share and think the latter company is worth twice as much. Of course, that is a completely meaningless comparison without also knowing how many shares outstanding there are for each of the two companies,
and then calculating their respective market caps. Comparing the share price of CCEL versus a peer is one thing; comparing
CCEL market cap versus a peer is a completely different story.
Furthermore, via fluctuation both in per-share price and in the number of shares outstanding (via issuance of new shares over time, the repurchase of existing shares),
the market cap for a company like CCEL can fluctuate over the course of history.
With this page we aim to empower investors researching CCEL by allowing them to research the CCEL market cap history. |
Free CCEL Email Alerts:
Video: The Importance of Market Cap
